Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban

Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban

Abstract Cancer‐associated venous thromboembolism (VTE) is a frequent, potentially life‐threatening event that complicates cancer management. Anticoagulants are the cornerstone of therapy for the treatment and prevention of cancer‐associated thrombosis (CAT); factor Xa–inhibiting direct oral anticoa...

Full description

Bibliographic Details
Main Authors: Rupert Bauersachs, Alok A. Khorana, Agnes Y. Y. Lee, Gerald Soff
Format: Article
Language:English
Published: Elsevier 2020-05-01
Series:Research and Practice in Thrombosis and Haemostasis
Subjects:
anticoagulants
cancer
neoplasms
rivaroxaban
thrombosis
venous thromboembolism
Online Access:https://doi.org/10.1002/rth2.12327

Internet

https://doi.org/10.1002/rth2.12327

Similar Items